Insurtech Investors

What are Insurtech investors, and what do they look for?

Insurance investors sort companies immediately by whether they carry risk. A business that distributes somebody else's policies, or sells software to insurers, is a commercial enterprise with software economics. A business that underwrites is a balance sheet with regulatory capital obligations, reserving requirements and a claims ratio that determines whether it makes money. These are entirely different investments, and the first minute of any pitch should make clear which one you are. For distribution and software businesses, investors look at the usual things plus one specific to insurance: whether the incumbent partner can replicate you. Insurers have large technology budgets and no shortage of consultants, so the question of why they buy rather than build is unavoidable. For underwriting businesses, everything reduces to whether you price risk better than the market. Investors will want evidence from actual claims experience, not from a model, and they know that early loss ratios flatter a young book because claims take time to develop. Across both, distribution economics matter enormously. Insurance is expensive to sell, customer acquisition costs are high, and policies must persist for years to recover them. Investors examine retention with particular attention because it determines whether the acquisition spend was ever worthwhile.

Why Insurtech is attracting investor interest

Distribution economics explain most of the recent investor interest. Selling insurance through traditional channels is costly, and embedding cover at the point where a customer buys something else, whether a car, a holiday, a piece of equipment or a delivery, changes the acquisition cost fundamentally. Investors like embedded models because they attack the largest inefficiency in the industry rather than competing on brand. Regulatory change opened doors as well. European rules on insurance distribution and on operational resilience have created obligations that incumbent systems handle poorly, generating demand for compliance and reporting tooling from buyers who cannot defer the purchase. Claims and underwriting data have become genuinely more useful. Telematics, connected devices, satellite imagery and better modelling allow risk to be assessed with information that was unavailable a decade ago, which supports both new products and better pricing on existing ones. Climate risk has become the sector's dominant strategic question. Rising physical risk is repricing property and agricultural cover across Europe, creating both a problem for insurers and an opportunity for companies that can model exposure, offer parametric products or serve risks the traditional market is withdrawing from.

Which funding stages Insurtech investors are active at

Stage structure in insurtech is determined by regulatory model more than by product maturity. Seed rounds fund a team, a distribution hypothesis and a regulatory route, which usually means operating as an intermediary or under a partner's permissions rather than seeking full underwriting authorisation immediately. Investors will assess whether that route is credible before assessing the product. Series A requires live distribution with real policies, evidence that acquisition costs are recoverable, and early persistency data. For underwriting businesses it also requires the beginning of a claims record, which investors treat cautiously because loss ratios on a young book are not yet meaningful. Series B and beyond diverges sharply. Software and distribution businesses follow enterprise software patterns. Underwriting businesses need capital to support growth in written premium, and that capital comes from reinsurance arrangements, capacity partners and regulatory capital rather than only from equity. Investors will assess whether you can secure capacity on sustainable terms. Growth capital in European insurtech is thinner than in fintech generally, and insurers themselves are the most active strategic investors and acquirers, which shapes the realistic outcome for many companies in the sector.

Typical check and round sizes in Insurtech

Naming typical figures would obscure the central variable, which is whether the company carries insurance risk. Distribution and software businesses raise on software patterns. Underwriting businesses face regulatory capital requirements that are a function of the risk written, and that capital is committed rather than available for growth. Capacity is the constraint founders most often underestimate. Whether a reinsurer or capacity partner will back your book, on what terms, and how those terms change if losses develop unfavourably, determines the economics more than any equity round. Securing capacity is a distinct workstream that takes time and relationships, and equity investors increasingly want to see it addressed before they commit. Acquisition cost recovery drives round sizing in distribution businesses. Insurance customers are expensive to acquire and the economics depend on multi-year persistency, which means the company funds a gap between spending and recovery. Rounds should be sized against that cycle explicitly. Reserving is a technical discipline that affects reported profitability substantially, and investors will look at whether reserves appear adequate rather than convenient. European public funding is largely irrelevant here compared with other sectors, so plan on private capital. For comparables, use recent European rounds from companies with the same regulatory model.

Types of investors active in Insurtech

What Insurtech investors look for in diligence

Insurtech diligence separates cleanly by model, and investors will establish which one you are before doing anything else. For underwriting businesses, loss ratio analysis dominates. Investors examine claims frequency and severity by cohort, how reserves have developed relative to initial estimates, and whether pricing has been adjusted as experience accumulated. They are alert to books too young to have developed claims and will discount favourable early ratios accordingly. Capacity arrangements are reviewed in detail: who provides it, on what terms, what happens if losses exceed expectations, and how much concentration risk sits in a single relationship. Regulatory position is checked properly. Which permissions you hold or operate under, what activities they cover, and what capital you are obliged to maintain. For distribution businesses, persistency is the central metric. Investors want retention by cohort and by channel over multiple renewal cycles, since insurance acquisition costs are only recovered through repeat renewal. Acquisition economics are built up fully, including commission structures and the timing of revenue recognition, which in insurance can differ substantially from cash receipt. For software businesses, the standard enterprise questions apply plus specific attention to implementation burden, since insurer integrations are notoriously long and services-heavy. Across all models, expect questions about claims handling quality, since poor claims experience destroys retention faster than anything else.

How to build a fundraising strategy as a Insurtech startup

State your regulatory and risk position in the first minute. Insurance investors filter on it immediately, and ambiguity leads them to assume the more capital-intensive interpretation. Being precise about whether you carry risk, distribute, or sell software saves everyone time. Secure capacity before you need to scale. For any underwriting model, a capacity partner willing to back growth is the binding constraint, and arranging it takes longer than an equity round. Arriving at a raise with capacity indicated puts you in a substantially stronger position. Present persistency rather than policy counts. Insurance is a renewal business, and investors know that acquisition without retention destroys value. Cohort persistency over several renewal cycles is the number that persuades. Be honest about book maturity. Claims develop over time, and presenting early loss ratios without acknowledging that they will deteriorate signals either inexperience or evasion. Investors respect founders who volunteer the caveat. Engage insurers strategically rather than opportunistically. They are the sector's most active investors and acquirers, and understanding what a given insurer needs, whether distribution, technology or access to a risk pool, makes the conversation far more productive. Consider embedded distribution seriously. It addresses the industry's largest cost problem, and investors are more receptive to it than to another consumer brand competing for attention against incumbents with vastly larger marketing budgets.

Common mistakes founders make raising Insurtech capital

Presenting a young book's loss ratio as though it were settled is the classic underwriting error. Claims take time to emerge, and an investor with insurance experience will apply development factors and reach a different conclusion than the one you presented. Underestimating regulatory capital catches founders who planned as though insurance were software. Capital held against written risk is not available for growth, and a plan that has not accounted for it is not a plan. Building consumer insurance brands on paid acquisition has repeatedly failed in Europe, because acquisition costs are high and persistency is often lower than modelled. Investors have watched several attempts and will test the assumptions carefully. Treating capacity as a commodity is dangerous. Capacity providers withdraw when losses develop badly, and a company dependent on one partner without alternatives can find its business unable to write new policies at short notice. Neglecting claims experience damages retention in ways that are slow to appear and hard to reverse. Companies that optimise acquisition and underinvest in claims handling discover the cost at renewal. Selling software to insurers without accounting for integration burden produces a services business with software valuations expectations. Insurer implementations are long, and companies that have not solved for that end up with revenue that does not scale.

How Insurtech investment differs across Europe

The UK has the largest and most sophisticated insurance market in Europe, anchored by the London specialty market, which gives access to underwriting expertise and capacity that exists almost nowhere else. Regulatory engagement with new entrants has been comparatively constructive, and the investor base is the deepest on the continent. Germany has a large, conservative insurance market dominated by established groups with strong distribution through tied agents. Displacing that is difficult, which has pushed German insurtech towards partnering with incumbents and towards business-facing products rather than direct consumer competition. France combines a large domestic market with substantial mutual and bancassurance distribution, meaning insurance is often sold alongside banking, and partnerships with financial institutions matter more than in other markets. Switzerland hosts significant reinsurance capacity and expertise, which is relevant to any company needing capacity or sophisticated risk modelling. The Nordics have high digital adoption and consumers comfortable buying insurance online, making the region a practical proving ground for direct models. The Netherlands has a competitive market with high price transparency and comparison shopping, which rewards efficient distribution and punishes weak pricing. Southern and Central Europe generally have lower insurance penetration, which represents genuine growth opportunity, alongside less developed local capital for the sector and greater reliance on incumbent distribution.